Limited Use Note(s)

Government of Ontario Logo
Reason For Use CodeClinical Criteria
23 As adjunctive therapy in the treatment of seizure disorders where control by other listed anticonvulsants has been unsatisfactory.
NOTE: Because a large number of patients will become refractory to the anticonvulsant effects of the drug over a period of time, the effectiveness of this drug must be re-evaluated after a period of six months.
LU Authorization Period: Indefinite.